Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
PT Prodia Widyahusada Tbk (PRDA.JK) is a company that specializes in providing private clinical laboratory services. Its service portfolio includes a comprehensive array of laboratory tests, specific diagnostic panel analyses, and various other forms of diagnostic support. By the end of 2021, specifically December 31st, the company had established a significant operational presence with 259 outlets dispersed across 34 provinces throughout Indonesia. This extensive network consisted of 10 Prodia Health Care and specialty clinics, 142 clinical and medical laboratories, 98 point-of-care facilities, and 9 collaborative laboratories situated within hospitals. Founded in 1973, Prodia Widyahusada maintains its corporate headquarters in Jakarta Pusat, Indonesia, and functions as a subsidiary of PT Prodia Utama.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of PRDA.JK is 3125 and suggests 20.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i